B细胞-话题@MedSci

#B细胞#

314篇内容 | 6301人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273306, encodeId=585112e330602, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效, objectType=article, longId=166508, objectId=9b0116650850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0116650850, replyNumber=0, likeNumber=69, createdTime=2019-05-22, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0116650850, moduleTitle=Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0116650850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273305, encodeId=57d212e3305bd, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=AGING CELL：B细胞的消耗使外周B细胞区室恢复活力, objectType=article, longId=165956, objectId=2e5716595617, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e5716595617, replyNumber=0, likeNumber=104, createdTime=2019-05-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e5716595617, moduleTitle=AGING CELL：B细胞的消耗使外周B细胞区室恢复活力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e5716595617)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273304, encodeId=53cf12e33047a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Clin Cancer Res:弥漫性大B细胞淋巴瘤（DLBCL）治疗耐药新机制, objectType=article, longId=164689, objectId=774b16468924, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=774b16468924, replyNumber=0, likeNumber=91, createdTime=2019-04-22, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=774b16468924, moduleTitle=Clin Cancer Res:弥漫性大B细胞淋巴瘤（DLBCL）治疗耐药新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=774b16468924)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273303, encodeId=cf9812e3303b1, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：PD-1/PD-L1和p53缺失协同促进弥漫性大B细胞淋巴瘤进展, objectType=article, longId=164252, objectId=ced71642525f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced71642525f, replyNumber=0, likeNumber=94, createdTime=2019-04-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced71642525f, moduleTitle=Blood：PD-1/PD-L1和p53缺失协同促进弥漫性大B细胞淋巴瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced71642525f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273302, encodeId=f55c12e3302d9, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：B细胞中的慢性CD30信号可促进淋巴瘤的发生, objectType=article, longId=163989, objectId=b073163989b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b073163989b6, replyNumber=0, likeNumber=84, createdTime=2019-04-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b073163989b6, moduleTitle=Blood：B细胞中的慢性CD30信号可促进淋巴瘤的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b073163989b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273301, encodeId=f27912e3301f9, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=原发性子宫及双侧附件弥漫性大B细胞淋巴瘤1例, objectType=article, longId=163896, objectId=6146163896f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6146163896f8, replyNumber=0, likeNumber=82, createdTime=2019-04-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6146163896f8, moduleTitle=原发性子宫及双侧附件弥漫性大B细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6146163896f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273300, encodeId=314f12e3300be, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：Parsaclisib，高选择性PI3Kδ抑制剂，可有效治疗复发性或难治性B细胞NHL, objectType=article, longId=163405, objectId=55c3163405ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c3163405ab, replyNumber=0, likeNumber=88, createdTime=2019-04-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c3163405ab, moduleTitle=Blood：Parsaclisib，高选择性PI3Kδ抑制剂，可有效治疗复发性或难治性B细胞NHL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c3163405ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273299, encodeId=e22d12e3299bd, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V2）, objectType=article, longId=163343, objectId=63e8163343c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63e8163343c3, replyNumber=0, likeNumber=24, createdTime=2019-04-01, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63e8163343c3, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63e8163343c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273298, encodeId=c14b12e3298c0, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, objectType=article, longId=162820, objectId=0e731628209a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e731628209a, replyNumber=0, likeNumber=86, createdTime=2019-03-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e731628209a, moduleTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e731628209a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273297, encodeId=d20312e329708, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Ann Rheum Dis：使用靶向B细胞的ianalumab（VAY736）治疗原发性干燥综合征, objectType=article, longId=161682, objectId=8b5b16168264, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b5b16168264, replyNumber=0, likeNumber=73, createdTime=2019-03-07, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b5b16168264, moduleTitle=Ann Rheum Dis：使用靶向B细胞的ianalumab（VAY736）治疗原发性干燥综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b5b16168264)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273296, encodeId=fe4d12e32966a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=鞍区粘膜相关性B细胞淋巴瘤1例, objectType=article, longId=161101, objectId=3eef16110132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eef16110132, replyNumber=0, likeNumber=101, createdTime=2019-02-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eef16110132, moduleTitle=鞍区粘膜相关性B细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eef16110132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273295, encodeId=c17f12e3295fe, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=加拿大批准Yescarta（Axicabtagene Ciloleucel）CAR T疗法治疗成人复发或难治性大B细胞淋巴瘤, objectType=article, longId=160891, objectId=16d216089137, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d216089137, replyNumber=0, likeNumber=69, createdTime=2019-02-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d216089137, moduleTitle=加拿大批准Yescarta（Axicabtagene Ciloleucel）CAR T疗法治疗成人复发或难治性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d216089137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273294, encodeId=560912e3294a4, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险, objectType=article, longId=160233, objectId=01b116023331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b116023331, replyNumber=0, likeNumber=79, createdTime=2019-02-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b116023331, moduleTitle=AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01b116023331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273293, encodeId=8cc712e329321, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Stem Cell Reports：科学家在小鼠体内制造出可供移植功能性B细胞, objectType=article, longId=160035, objectId=55b1160035bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55b1160035bb, replyNumber=0, likeNumber=94, createdTime=2019-02-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55b1160035bb, moduleTitle=Stem Cell Reports：科学家在小鼠体内制造出可供移植功能性B细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55b1160035bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273292, encodeId=c2d512e3292af, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：MHC II类细胞可自主调节正常和恶性B细胞的自我更新和分化, objectType=article, longId=159604, objectId=43ae1596044f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43ae1596044f, replyNumber=0, likeNumber=111, createdTime=2019-02-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43ae1596044f, moduleTitle=Blood：MHC II类细胞可自主调节正常和恶性B细胞的自我更新和分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43ae1596044f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273291, encodeId=6cd012e3291ac, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞, objectType=article, longId=159378, objectId=d85f1593e830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85f1593e830, replyNumber=0, likeNumber=74, createdTime=2019-02-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85f1593e830, moduleTitle=INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85f1593e830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273290, encodeId=e84012e3290de, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=INT J LAB HEMATOL：对286个成熟B细胞肿瘤的整合流式细胞术分析显示，CD13可作为诊断亚型的有用标记, objectType=article, longId=159375, objectId=c0fc1593e543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0fc1593e543, replyNumber=0, likeNumber=66, createdTime=2019-02-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0fc1593e543, moduleTitle=INT J LAB HEMATOL：对286个成熟B细胞肿瘤的整合流式细胞术分析显示，CD13可作为诊断亚型的有用标记, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0fc1593e543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273289, encodeId=fcf412e328924, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=2019 BSH更佳实践指南：原发性纵膈B细胞淋巴瘤的管理, objectType=article, longId=159138, objectId=e15f159138c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e15f159138c6, replyNumber=0, likeNumber=36, createdTime=2019-01-30, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e15f159138c6, moduleTitle=2019 BSH更佳实践指南：原发性纵膈B细胞淋巴瘤的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e15f159138c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273288, encodeId=503c12e3288e8, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=膀胱弥漫大B细胞淋巴瘤侵及回肠1例, objectType=article, longId=158745, objectId=d7d4158e45d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d4158e45d0, replyNumber=0, likeNumber=82, createdTime=2019-01-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d4158e45d0, moduleTitle=膀胱弥漫大B细胞淋巴瘤侵及回肠1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d4158e45d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273287, encodeId=e46212e32878f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, objectType=article, longId=158333, objectId=632d1583337f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=632d1583337f, replyNumber=0, likeNumber=73, createdTime=2019-01-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=632d1583337f, moduleTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=632d1583337f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效

2019-05-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

AGING CELL：B细胞的消耗使外周B细胞区室恢复活力

2019-05-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Clin Cancer Res:弥漫性大B细胞淋巴瘤（DLBCL）治疗耐药新机制

2019-04-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：PD-1/PD-L1和p53缺失协同促进弥漫性大B细胞淋巴瘤进展

2019-04-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：B细胞中的慢性CD30信号可促进淋巴瘤的发生

2019-04-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

原发性子宫及双侧附件弥漫性大B细胞淋巴瘤1例

2019-04-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：Parsaclisib，高选择性PI3Kδ抑制剂，可有效治疗复发性或难治性B细胞NHL

2019-04-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2019.V2）

2019-04-01

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤

2019-03-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Ann Rheum Dis：使用靶向B细胞的ianalumab（VAY736）治疗原发性干燥综合征

2019-03-07

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

鞍区粘膜相关性B细胞淋巴瘤1例

2019-02-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

加拿大批准Yescarta（Axicabtagene Ciloleucel）CAR T疗法治疗成人复发或难治性大B细胞淋巴瘤

2019-02-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险

2019-02-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Stem Cell Reports：科学家在小鼠体内制造出可供移植功能性B细胞

2019-02-16

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：MHC II类细胞可自主调节正常和恶性B细胞的自我更新和分化

2019-02-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞

2019-02-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

INT J LAB HEMATOL：对286个成熟B细胞肿瘤的整合流式细胞术分析显示，CD13可作为诊断亚型的有用标记

2019-02-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

2019 BSH更佳实践指南：原发性纵膈B细胞淋巴瘤的管理

2019-01-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

膀胱弥漫大B细胞淋巴瘤侵及回肠1例

2019-01-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案

2019-01-19

科室
- - 订阅+
  - 更多科室
工具
服务